Author:
CostaPinto Licia,Olavarria Viviana Gallazzi,Grassi Maria Fernanda Rios,Lyrio Leomar D’ Cirqueira,Oliveira Rone Peterson Cerqueira,Santana Iuri Usêda,Cruz Cristiane Bahiana,Santiago Mittermayer Barreto
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference49 articles.
1. CDC Grand Rounds (2011) Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep 60(12):370–373
2. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D et al (2010) Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 340:c1642. doi: 10.1136/bmj.c1642
3. Unemo M, Rossouw A, James V, Jenkins C (2009) Can the Swedish new variant of Chlamydia trachomatis (nvCT) be detected by UK NEQAS participants from seventeen European countries and five additional countries/regions in 2009? Euro Surveill 14(19):pii=19206. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19206
4. Wilson JS, Honey E, Templeton A, Paavonen J, Mardh PA, Stray-Pedersen B (2002) A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 8(4):385–394
5. de Codes JS, Cohen DA, de Melo NA, Teixeira GG, Leal AS, Silva TJ et al (2006) Screening of sexually transmitted diseases in clinical and non-clinical settings in Salvador, Bahia, Brazil. Cad Saude Publica 22(2):325–334
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献